Pulmonary Embolism Pathway

Similar documents
Suspected Deep Vein Thrombosis (DVT) Assessment

PE Pathway. The charts are listed as follows:

Pathology Service User Guide Haematology

Suspected Pulmonary embolus Ambulatory Pathway. Document Title. Date Issued/Approved: Date Valid From: 11/11/17. Date Valid To: 11/05/18

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine

Pulmonary Embolism. Pulmonary Embolism. Pulmonary Embolism. PE - Clinical

PULMONARY EMBOLISM MANAGEMENT GUIDELINES

Suspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range

DVT - initial management NSCCG

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow

Dr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital Foundation Trust

Venous Thromboembolism Prophylaxis

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None

PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT

Management of Acute Pulmonary Embolism. Judith Hurdman Consultant Respiratory Physician

Venous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community

DEEP VEIN THROMBOSIS (DVT): TREATMENT

Guidelines for slow loading of patients on warfarin for Atrial Fibrillation (AF) in the non acute setting

Understanding Best Practices in Anticoagulation Therapy in Patients with Venous Thromboembolism. Rajat Deo, MD, MTR

Venous Thromboembolism (VTE)

1. SCOPE of GUIDELINE:

Treatment of deep vein thrombosis and pulmonary embolism with low molecular weight heparin

URN: Family name: Given name(s): Address: Initial Signature Print Name Role

SAFETY OF A PULMONARY EMBOLISM AMBULATORY TREATMENT PROGRAM

ADULT TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) TELEMETRY BED TRANSFER ORDERS 1 of 4

PREOPERATIVE ANAEMIA PATHWAY

Warfarin in Adults : Guidelines for the use of. These guidelines apply to all patients commenced or continuing on warfarin

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2012) NICE guideline CG144

CLINICAL PROCEDURAL DOCUMENT

Trust Guideline for the Management of: Condition or Procedure in Adults and / or Children

Prevention and treatment of venous thromboembolic disease

NUH Emergency Department. Guideline for Diagnosis & Treatment of PE (Massive and Non-Massive) in Adults only

Acute Pulmonary Embolism and Deep Vein Thrombosis. Barbara LeVarge MD Beth Israel Deaconess Medical Center Pulmonary Hypertension Center COPYRIGHT

Outpatient Treatment of Deep Vein Thrombosis with Low Molecular Weight Heparin (LMWH) Clinical Practice Guideline August 2015

SAFE approach. Unresponsive? Shout or call for help. Open Airway. Not Breathing normally? 30 chest compressions. 2 rescue breaths

Shared Care Protocol for the Prescription and Supply of Low Molecular Weight Heparins

Deep vein thrombosis: diagnosis, prevention and treatment

PE service. 65 years old lady. What would you do next? Risk stratification. What would you do next? Regional College Lecture PE Management

DOAC and NOAC are terms for a novel class of directly acting oral anticoagulant drugs including Rivaroxaban, Apixaban, Edoxaban, and Dabigatran.

Edoxaban Treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism (NICE TA354)

Dr Ben Edwards Consultant Anaesthetist Sheffield Teaching Hospitals

Anticoagulation in Special populations. Ng Heng Joo Department of Haematology Singapore General Hospital

THROMBOSIS RISK FACTOR ASSESSMENT

Venous Thromboembolic Disease Update

Deep vein thrombosis (DVT) and pulmonary embolism (PE) advice for ophthalmic surgery patients

PULMONARY EMBOLISM -CASE REPORT-

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD

DVT Primary Care Prescribing Pathway

Management of Cancer Associated Thrombosis (CAT) where data is lacking. Tim Nokes Haematologist, Derriford Hospital, Plymouth

FRACTURED NECK OF FEMUR CLINICAL PATHWAY

Reporting SPECT-VQ. Alp Notghi

How long to continue anticoagulation after DVT?

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)

Edoxaban for the treatment and prevention of venous thromboembolism (DVT or PE) or stroke prevention in non-valvular AF

CANCER ASSOCIATED THROMBOSIS. Pankaj Handa Department of General Medicine Tan Tock Seng Hospital

Jessica Bryan, Natalia Evans, Karlyn Henderson, & Whitney Parks

RISK STRATIFICATION OF PATIENTS WITH ACUTE SYMPTOMATIC PULMONARY EMBOLISM. David Jiménez, MD, PhD, FCCP Ramón y Cajal Hospital, IRYCIS Madrid, Spain

Appendix 2H - SECONDARY CARE CONVERSION GUIDELINES ORAL ANTICOAGULANTS

The spectrum of clinical outcome of PE

Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge

Anticoagulation in Special populations. Ng Heng Joo Department of Haematology Singapore General Hospital

Acute Management of Pulmonary Embolism

GENERAL SURGICAL ADULT POST-OPERATIVE ORDERS 1 of 4

These are guidelines only and can be deviated from if it is thought to be in the patient s best interest.

Low Molecular Weight Heparin for Prevention and Treatment of Venous Thromboembolic Disorders

Duration of anticoagulation

Prevention of Venous Thromboembolism

Ambulatory Emergency Care Pathways. Painless Obstructive Jaundice

Acute and long-term treatment of PE. Cecilia Becattini University of Perugia

Venous Thromboembolism (VTE) Prevention and Treatment of VTE in Patients Admitted to Hospital

CHAPTER 2 VENOUS THROMBOEMBOLISM

Trust Guideline for the Management of: Adult patients requiring anticoagulation with Warfarin (including reversal)

DVT and Pulmonary Embolus. Dr Piers Blombery BSc(Biomed), MBBS (Hons), FRACP, FRCPA Consultant Haematologist Peter MacCallum Cancer Centre

Accompanied to walk Yes No Accompanied to walk Yes No Side of Fracture

PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP

Pulmonary Thromboembolism

North East Essex Medicines Management Committee

Is it safe to manage pulmonary embolism in Primary Care? Roopen Arya King s College Hospital

Cancer of Unknown Primary Service

*Abuelmagd Abdalla Department of General Internal Medicine, University College Hospital Galway, Galway, Ireland

Title Use and monitoring of Low Molecular Weight Heparins (LMWHs) in community hospitals and community nursing Clinical Guidelines

CARDIAC CHEST PAIN. 1. ST Elevation MI

THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY

Obesity, renal failure, HIT: which anticoagulant to use?

Deep Vein Thrombosis

Pulmonary embolism: Acute management. Cecilia Becattini University of Perugia, Italy

Venous Thromboembolism National Hospital Inpatient Quality Measures

Development of an RANP role, Acute Medicine. Emily Bury RANP, Acute Medicine

Deep Vein Thrombosis and Pulmonary Embolism: Patient Information

Lung Cancer - Suspected

VTE Prevention Guidelines (Venous Thromboembolism) (Venous Thromboembolism)

ADULT CARDIAC SURGERY TELEMETRY BED TRANSFER ORDERS 1 of 4

Objectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk?

CARDIAC PROBLEMS IN PREGNANCY

Are guidelines for anticoagulation useful in cancer patients?

Misunderstandings of Venous thromboembolism prophylaxis

Clinical Policy: Dalteparin (Fragmin) Reference Number: ERX.SPA.207 Effective Date:

Transcription:

Pulmonary Embolism Pathway Ambulatory Care Pathway Dr. A. Zafar, Dr. A. Rehman, Dr. T. Malik September, 2011. Patient Identification Label

Pulmonary Embolism Pathway Clinical History Comments Hospital Admission in last 90 days Surgery in last six months Smoker OCP/HRT Pregnant Refer to Flow Chart Malignancy Long Haul Travel (> 2hours) Previous thrombotic episode Family History of thrombosis WELLS SCORE Clinically Suspected DVT Alternative diagnosis is less likely than PE Pulse rate > 100 Immobilisation/surgery in previous 4 weeks History of DVT/PE Haemoptysis Malignancy (treatment for within 6 months, palliative) 3.0 3.0 1.5 1.5 1.5 1.0 1.0 CTPA Request Requirements: Mark request form For Ambulatory Pathway Wells Score D. Dimer Result Creatinine determination of creatinine clearance must not delay or modify administration of first does of LMWH Pink or Green Cannula (preferably at antecubital fossa) 2 P a g e

SUSPECTED SUSPECTED PE PE SOB SOB ± Pleuritic ± Pleuritic Chest Chest Pain, Pain, ± tachypnoea ± tachypnoea ± Haemoptysis ± Haemoptysis Clinical History including assessment for DVT Baseline Investigations: FBC, U & E, CRP, LFT, Coagulation Screen, ABG, CXR, ECG & D.Dimer Is patient physiologically stable? Oxygen Sats > 93%, Systolic BP > 100, Pulse < 100 and no confusion Marked hypotension, Systolic BP < 90, Profound Hypoxaemia Assess Probability According to Wells Score If Score > 4 PE Likely, start LMWH NEG for PE D. Dimer +ve CTPA If score < 4 Start LMWH POSITIVE for PE D. Dimer -ve Consider alternative diagnosis If imaging is not immediately available consider discharge on LMWH with next day recall for CTPA as ambulatory care Consider other diagnosis Physiologically stable Possible Massive PE Consultant to Consultant discussion Arrange Urgent CTPA & Echo Consider Thrombolysis Ambulatory care for confirmed PE START WARFARIN Admit for Inpatient Care All pregnant patients with suspected PE MUST be reviewed by the Obstetric Team 3 P a g e

Subcutaneous low molecular weight heparin (LMWH) Schedule (Using Tinzaparin Sodium in a strength of 20.000 Xa IU in 1 ml) Where patients are in renal failure (Creatinine Clearance <30 ml/min), it is essential to discuss anticoagulant management with a consultant haematologist. Determination of creatinine clearance must not delay or modify administration of first dose. Recommended treatment for patients with DVT in the absence of pregnancy (caution in acute Asthma) Pre-filled syringes of Tinzaparin can be used in pregnancy. Vials of Tinzaparin contain Benzyl alcohol which must be avoided in pregnancy. Once daily S/C injection based on body weight. Tick appropriate weight and dose used in box below Weight Kg Treatment with LMWH must continue for 6 days. Thereafter, it should not be stopped unless the INR is stable and within the therapeutic range of 2.0-3.0 or 3.0-4.0. Monitor platelets after 4 days of heparin treatment DATE: / / TICK Weight (Kg) Dose (ml) TICK Weight (Kg) Dose (ml) 130 1.15 80 0.70 125 1.10 75 0.65 120 1.05 70 0.60 115 1.00 65 0.55 110 0.95 60 0.55 105 0.90 55 0.50 100 0.90 50 0.45 95 0.85 45 0.40 90 0.80 40 0.35 85 0.75 4 P a g e

THROMBOPHILIA SCREENING TOOL Please tick below 1. DIAGNOSIS Was the VTE a sponatenous event? Was the VTE in an unusual site? E.g. axillary, mesenteric Is the patient < 45 years old? 2. PATIENT HISTORY Is there a previous history of spontaeneous PE or DVT? Is there a history of recurrent foetal loss (more than 3)? Is there a family history of thrombophillia? (Refer) Does the patient require Thrombophillia screening Date Signature 5 P a g e

Confirmed PE Ambulatory Clinic Work Up Consider Haematology referral for:- 1. Unprovoked PE 2. <45 years old 3. Strong family history of Thrombophillia 4. Recurrent PE s Consider Respiratory Referral for:- 1. Recurrent shortness of breath 2. Decompensated Corpulmonale For respiratory please order:- ECHO Lung Function Tests GP 6 P a g e

Criteria for suspected PE patients to be treated as outpatients: Are any of the following present? 1. Patient unstable Syncopal episode Haemodynamically unstable BP<100/60 Haemodynamically unstable P>100 Haemodynamically unstable RR>24 O2 sat<93% on air/requiring O2 Prior cardiorespiratory disease including PE Coexisting major DVT (high segment femoral and above) PE while on anticoagulation Chest pain not managed by oral analgesia 2. Severe renal dysfunction (egfr<30ml/min/11.73m 2 3. Active malignancy 4. Pregnant 5. Bleeding risk Coagulopathy Active bleeding Intracranial haemorrhage ever GI/GU bleed, trauma, surgery in past month Platelets<50 6. Allergy to warfarin/heparin or history HIT 7. Outpatient therapy not feasible in terms of - immobility compliance unlikely unable to obtain transport to and from hospital unable to access telephone at home unaware of adverse symptoms and how to obtain help If the answer to any of the above is yes then the patient should be admitted. Refs: Davies CWH, Wimperis J, Green ES, et al. Early discharge of patients with pulmonary embolism: a two-phase observational study, Eur Respir J 2007;30: 708-714 Hamad M, Chembo C, Ellidir E, et al. Safety of a pulmonary embolism ambulatory treatment (PEAT) program. Abstract at 2 nd conference of Society for Acute Medicine 2008. 7 P a g e

AMBULATORY CARE PATHWAY FOR CONFIRMED PULMONARY EMBOLISM Is the patient suitable for Ambulatory Care? Continue inpatient care Is patient/carer/partner able to administer LMWH DN service able to administer LMWH Home with LMWH supplies and Warfarin starter pack Go through checklist with patients and give copy MAU staff administer daily LMWH until INR therapeutic. Go through checklist with patients and give copy Refer to SWFT anticoagulant clinic electronically Print copy of referral and file in notes Consider outpatient or GP investigations of underlying causes (eg prostatic, urological or gynaecological tumours, other occult malignancy or infection, thrombophillia 8 P a g e

Pretest Probabilty for Malignancy Following Positive PE UR Number Name: Ultra sound scan Date: / / Calf Popliteal Femoral iliac Other Site Address: Preveious Thromboic History: Tel : GP: Known Malignancy Weight Loss > 7lbs in 6 months Recent Abdominal Pain Recent Alteration in Bowel Habit Haematurea / Malaena Bilateral DVT Unexplained PV Bleeding = Gynaecological Referral to any of the above questions refer patient for ABDOMINAL ULTRA SOUND SCAN Smoker or smoked within last 5 years Male > 60 years Male < 60 years with urinary problems Raised Plasma Viscosity = chest x-ray PSA PSA Biochemistry Screen Does patient require further screening for cancer History Taken By:- Date:- 9 P a g e